======= USP21 ======= == Gene Information == * **Official Symbol**: USP21 * **Official Name**: ubiquitin specific peptidase 21 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=27005|27005]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9UK80|Q9UK80]] * **Interactions**: [[https://thebiogrid.org/search.php?search=USP21&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20USP21|Open PubMed]] * **OMIM**: [[https://omim.org/entry/604729|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Deubiquitinates histone H2A, a specific tag for epigenetic transcriptional repression, thereby acting as a coactivator. Deubiquitination of histone H2A releaves the repression of di- and trimethylation of histone H3 at 'Lys-4', resulting in regulation of transcriptional initiation. Regulates gene expression via histone H2A deubiquitination (By similarity). Also capable of removing NEDD8 from NEDD8 conjugates but has no effect on Sentrin-1 conjugates (PubMed:10799498). Deubiquitinates BAZ2A/TIP5 leading to its stabilization (PubMed:26100909). {ECO:0000250|UniProtKB:Q9QZL6, ECO:0000269|PubMed:10799498, ECO:0000269|PubMed:26100909}. |UCH| |NEDD8-specific protease activity| |histone deubiquitination| |cysteine-type peptidase activity| |thiol-dependent ubiquitinyl hydrolase activity| |thiol-dependent ubiquitin-specific protease activity| |protein deubiquitination| |transcription coactivator activity| |protein modification by small protein removal| |histone modification| |covalent chromatin modification| |ubiquitin-dependent protein catabolic process| |modification-dependent protein catabolic process| |modification-dependent macromolecule catabolic process| |proteolysis involved in cellular protein catabolic process| |cellular protein catabolic process| |neuron projection development| |protein catabolic process| |chromatin organization| |neuron development| |cellular macromolecule catabolic process| |protein modification by small protein conjugation or removal| |neuron differentiation| |macromolecule catabolic process| |organonitrogen compound catabolic process| |chromosome organization| |plasma membrane bounded cell projection organization| |cell projection organization| |proteolysis| |generation of neurons| |positive regulation of transcription, DNA-templated| |neurogenesis| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |cell development| |positive regulation of RNA metabolic process| |organic substance catabolic process| |cellular catabolic process| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp108|Vinblastine 0.2μM R03 exp108]]|-1.79| |[[:results:exp341|BRD2 inhibitor II 20μM R07 exp341]]|1.75| |[[:results:exp389|PF-06409577 20μM R07 exp389]]|1.91| |[[:results:exp391|Pomalidomide 20μM R07 exp391]]|1.93| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 1/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/25| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|1/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 15351 * **Expression level (log2 read counts)**: 5.06 {{:chemogenomics:nalm6 dist.png?nolink |}}